Tuberculosis, Pulmonary clinical trials
The registry lists 339 studies for Tuberculosis, Pulmonary across more than 10 countries. 70 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-25.
Status
- Completed
- 184
- Status unknown
- 54
- Recruiting
- 45
- Not yet recruiting
- 23
- Active, not recruiting
- 11
- Terminated
- 9
Phase
- Phase 2
- 100
- Phase 3
- 55
- Phase 1
- 29
- Phase 4
- 19
- Early Phase 1
- 2
Where
- South Africa
- 79
- China
- 33
- India
- 30
- Uganda
- 28
- United States
- 27
- Tanzania
- 22
Who runs them
Global Alliance for TB Drug Development (21) · National Institute of Allergy and Infectious Diseases (NIAID) (18) · Johns Hopkins University (9) · Michael Hoelscher (9) · Beijing Chest Hospital (9) · Seoul National University Hospital (7) · National University Hospital, Singapore (7) · Centers for Disease Control and Prevention (5)
Studies
Recruiting first, then most recently updated. Showing 50 of 339 — search for more.
- Study of Combinations of Novel Promising Drugs for Pulmonary TuberculosisNot yet recruitingNCT07773610Phase 21 country
- Digital Health Intervention to Improve TPT UptakeRecruitingNCT07313995Not applicable1 country
- The LalelaLung Study: Digital Stethoscope Clinical EvaluationNot yet recruitingNCT07631377Phase 4
- Fibroblast Activating Protein (FAP) PET/CT in Adults With TuberculosisRecruitingNCT07830771Early Phase 11 country
- Trial of Novel Regimens for the Treatment of Pulmonary TuberculosisRecruitingNCT06192160Phase 214 countries
- Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory TrialRecruitingNCT07118059Phase 21 country
- Program for Rifampicin-Resistant Disease With Stratified Medicine for TuberculosisRecruitingNCT06441006Phase 2/35 countries
- Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TBNot yet recruitingNCT06205589Phase 2
- Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TBRecruitingNCT07672405Phase 22 countries
- A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)Not yet recruitingNCT07595042Phase 216 countries
- Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, TrialRecruitingNCT06727864Phase 31 country
- A Step Forward for Unraveling the Immune Mechanisms and Tools for Tuberculosis Spectrum ManagementNot yet recruitingNCT07735754
- Shortened Regimen for Drug-susceptible TB in ChildrenRecruitingNCT06253715Phase 37 countries
- Effectiveness of Psychosocial Counseling in Patients With a New Tuberculosis DiagnosisNot yet recruitingNCT07703696Not applicable1 country
- Evaluating Urine Isoniazid Testing to Detect Nonadherence to Tuberculosis Medications in IndiaEnrolling by invitationNCT06526221Not applicable1 country
- Artificial Intelligence-driven Tuberculosis Landscape Analysis & Stratification ResearchNot yet recruitingNCT076116951 country
- A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary TuberculosisRecruitingNCT07209761Phase 38 countries
- Blood Tuberculosis DNA Levels to Monitor Tuberculosis TreatmentRecruitingNCT068456181 country
- 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis PatientsRecruitingNCT070772131 country
- Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)RecruitingNCT07164742Not applicable1 country
- AIPH-TB: AI-Optimised Pyrazinamide-Hydroxychloroquine vs Standard RIPE for Drug-Sensitive Pulmonary Tuberculosis - A Phase II RCTNot yet recruitingNCT07467252Phase 21 country
- Remimazolam for Bronchoscopy in High-Risk PatientsRecruitingNCT07395596Phase 41 country
- ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)RecruitingNCT07303699Phase 21 country
- Pragmatic Optimized Rifampicin TrialRecruitingNCT06057519Phase 32 countries
- Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in TuberculosisRecruitingNCT07073638Phase 21 country
- Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and VomitingRecruitingNCT07271225Not applicable1 country
- Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese CohortNot yet recruitingNCT07268664Phase 31 country
- A PAN-USR TB Multi-Center TrialRecruitingNCT06905522Phase 31 country
- DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary TuberculosisRecruitingNCT065853581 country
- Plasma MTB cfDNA Before BronchoscopyNot yet recruitingNCT072304571 country
- PanACEA - STEP2C -01RecruitingNCT05807399Phase 26 countries
- Platform Assessing Regimens and Durations In a Global Multisite Consortium for TBRecruitingNCT06114628Phase 25 countries
- ATORvastatin in Pulmonary TUBerculosisRecruitingNCT06199921Phase 21 country
- Evaluation of PATHFAST-LAM as a Tuberculosis Treatment Monitoring Tool in KenyaNot yet recruitingNCT071579041 country
- Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible TuberculosisNot yet recruitingNCT07129629Phase 2
- Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis DiseaseNot yet recruitingNCT07118696Phase 3
- Ultra-Short Regimen for Elderly DS-TBNot yet recruitingNCT07076225Phase 3
- A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis PatientsRecruitingNCT05824871Phase 31 country
- ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74RecruitingNCT06714513Phase 11 country
- Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective StudyNot yet recruitingNCT069229161 country
- Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using DoxycyclineRecruitingNCT06477185Phase 21 country
- Novel Triple-dose Tuberculosis Retreatment RegimenRecruitingNCT04260477Phase 31 country
- Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled BreathRecruitingNCT065284181 country
- Drug-Drug Interaction and Food Effect of Sudapyridine(WX-081) With Itraconazole and Rifampin in Healthy Chinese AdultsNot yet recruitingNCT06701136Phase 1
- Post TB Sequelae StudyEnrolling by invitationNCT067441791 country
- A Systemic Screening for TB Disease in High-risk Groups in BarcelonaRecruitingNCT067065961 country
- Observation Study on the Efficacy of Yiqi Gubiao Pill in the Treatment of Chronic Obstructive Pulmonary Disease Secondary to Active Pulmonary TuberculosisNot yet recruitingNCT06676800Early Phase 1
- Atorvastatin to Reduce Inflammation After Tuberculosis Treatment CompletionRecruitingNCT04147286Phase 2/31 country
- A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TBNot yet recruitingNCT06526039Phase 3
- The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)RecruitingNCT06476210Phase 41 country